Aquipta Use In Pregnancy & Lactation

Pregnancy: There are limited data from the use of atogepant in pregnant women. Studies in animals have shown reproductive toxicity (see Toxicology: Preclinical safety data under Actions). Atogepant is not recommended during pregnancy and in women of childbearing potential not using contraception.
Breast-feeding: Pharmacokinetic data after single-dose administration showed minimal transfer of atogepant into breast milk (see Pharmacology: Pharmacokinetics under Actions).
There are no data on the effects of atogepant on the breastfed infant or the effects of atogepant on milk production.
The developmental and health benefits of breast-feeding should be considered along with the mother's clinical need for atogepant and any potential adverse effects on the breastfed infant from atogepant or from the underlying maternal condition.
Fertility: No human data on the effect of atogepant on fertility are available. Animal studies showed no impact on female and male fertility with atogepant treatment (see Pharmacology: Toxicology: Preclinical safety data under Actions).